Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

GLOBAL MARKETS-Record high stocks bask in November reign

Published 11/17/2020, 06:01 PM
Updated 11/17/2020, 06:10 PM
©  Reuters
JP225
-
DX
-
LCO
-
CL
-
DE10YT=RR
-
IT10YT=RR
-
STOXX
-
MIAPJ0000PUS
-
CSI300
-
MRNA
-

* World stocks at record high on vaccine optimism
* Oil adds to 16% November surge
* Dollar weakens on rising case numbers, yuan rising
* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn
* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
*

By Marc Jones
LONDON, Nov 17 (Reuters) - World stock markets grabbed a
well-earned breather on Tuesday after a second major coronavirus
vaccine boost in the space of a week had propelled them higher
again and put Europe on course for its best month in nearly
three decades.
The pan-European STOXX 600 dipped 0.2% .STOXX in early
moves but there was little sign of an end to the November bull
run that has also seen confidence-sensitive commodities and
emerging markets surge. .EU EMRG/FRX
MSCI's main 49-country world stocks index was perched at a
record high having risen 11% and all but once this month, while
China's yuan hit a near 2-1/2 year peak in the currency markets
as the U.S. dollar continued to sag. /FRX Investors are in "full bull" mode, BofA's monthly investor
survey showed on Tuesday. With global economic growth and profit expectations running
at a 20-year high among those the bank surveyed, the "reopening
rotation" back into coronavirus-hit sctors is likely to continue
for the rest of the year, BofA added, although they did also
recommend cashing in in the coming weeks or months.
The latest boost come from Moderna MRNA.O which said on
Monday its experimental COVID-19 vaccine was 94.5% effective in
preventing infection based on interim late-stage data.
The U.S.-based firm became the second drugmaker, after
Pfizer PFE.N , to announce promising data. Its shares gained
9.6% on the day. MSCI's broadest index of Asia-Pacific shares outside Japan
.MIAPJ0000PUS gained 0.2% overnight, a day after hitting its
highest level since launching in 1987.
Japan's Nikkei 225 .N225 rose 0.4% after hitting a 29-year
high the day before, but Chinese blue chips .CSI300 dipped as
recent bond defaults hit sentiment.
"The market is assuming that we can see the end of the
tunnel, that in 2022 a large part of the world's population will
start to receive access to vaccines," said Herald van der Linde,
HSBC's head of equity strategy for Asia Pacific.
There were initial indications that this was sparking a
change in investors' attitudes, he added.

OIL ON THE BOIL
The positive vaccine news helped oil prices add to their 16%
November gains.
U.S. crude CLc1 inched up to $41.57 per barrel after
rising 3.02% on Monday, and Brent LCOc1 gained 0.7% after a
2.43% jump the day before.
In currency markets, China's central bank on Tuesday lifted
its official yuan midpoint to the highest in nearly 29 months,
underpinned by solid gains in spot prices a day earlier on the
back of strong economic data. The vaccine news also helped the risk-friendly Australian
dollar AUD=D4 , which climbed to a one-week high against its
U.S. counterpart. Rising virus case numbers in the United States
clouded views on the dollar, which dropped against a basket of
major currencies =USD .
Euro zone bond markets showed little reaction to Hungary and
Poland's veto of the EU's budget and recovery fund in early
Tuesday trade.
Italy was expected to sell a U.S. dollar bond while China
was preparing for a potentially record euro-denominated bond
sale which was due to be finalised on Wednesday.
Euro zone bonds, which sold off moderately and then recouped
losses later on Monday, were steady in early Tuesday trade, with
Germany's 10-year benchmark yield at -0.55% DE10YT=RR and
Italy's 10-year yield at 0.61%. IT10YT=RR
The closely watched gap between Italian and German 10-year
yields -- effectively the risk premium on debt from Italy, one
of the main beneficiaries of the recovery fund - was near its
lowest since early 2018 at around 115 basis points.
The lack of market reactions "tend to reflect the market's
view that the EU will find a way to hammer out a compromise that
keeps all parties roughly happy," Andy Cossor, a strategist at
DZ Bank, said of the Polish and Hungarian vetoes.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Global assets http://tmsnrt.rs/2jvdmXl
Global currencies vs. dollar http://tmsnrt.rs/2egbfVh
Emerging markets http://tmsnrt.rs/2ihRugV
MSCI All Country Wolrd Index Market Cap http://tmsnrt.rs/2EmTD6j
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.